BHCHX Mutual Fund

BHCHX Mutual Fund

NAV$24.46
See how much of BHCHX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 30, 2026

Net Assets
$63M
Expense Ratio
0.85%
Dividend Yield (Current)
-
Holdings
33
Inception Date
Apr 30, 2018
Fund Family
Baron Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Unspecified

Performance

YTD+15.23%
1 Year+22.37%
3 Year+12.89%
5 Year+2.20%

Asset Allocation

Stocks: 100.00%
See how much of BHCHX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co14.25%
MTDMettler-Toledo International Inc.7.44%
JNJJohnson & Johnson - Common7.30%
TMOThermo Fisher5.92%
TEVA:ILTeva Pharmaceutical Industries Limited (Adr)5.07%
Top 10 Concentration: 61.10%Report Date: Sep 30, 2026
Download all 33 holdings for BHCHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Unspecified
Latest Distribution
$0.22
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

BHCHX Mutual Fund Overview

BHCHX Mutual Fund (Baron Health Care Fund Institutional Shares) is managed by Baron Funds with $62.9M in net assets. BHCHX expense ratio is 0.85%, holding 33 positions across sectors including Health Care, Real Estate, Financials. Inception date: 2018-04-30.

BHCHX performance shows a YTD return of 15.23%. The 1-year return is 22.37% and the 5-year return is 2.20%.

BHCHX top holdings include Eli Lilly & Co (14.3%), Mettler-Toledo International Inc. (7.4%), Johnson & Johnson - Common (7.3%), Thermo Fisher (5.9%), Teva Pharmaceutical Industries Limited (Adr) (5.1%). Go to all BHCHX holdings, BHCHX sectors, or BHCHX dividends.

BHCHX can be compared against other funds. Use BHCHX overlap to find shared positions, or BHCHX vs another fund for a side-by-side view. BHCHX alternatives are available via the screener, along with tax-loss harvesting opportunities.